Form 4: Xtant Medical Holdings Director Receives Stock Grant
Insider Transaction (Form 4)
Stavros G. Vizirgianakis, a Director of Xtant Medical Holdings, Inc., received 323,275 shares of common stock on August 15, 2026.
Summary
- Grant/award: acquired 323,275 Common Stock on August 15, 2026; holds 7,838,845 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Stavros G. Vizirgianakis — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-15 | Grant/award | Common Stock | 323,275 | — | — | 7,838,845 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-15 | Grant/award (323,275 shares) |
Keywords
insider transaction, Form 4, XTNT, Xtant Medical Holdings, Inc., neutral, Stavros G. Vizirgianakis
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.